Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
评估两种纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤患者的给药方案:来自 IIIb/IV 期 CheckMate 511 试验的结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.18.01998
Lebbé, Celeste; Meyer, Nicolas; Mortier, Laurent; Marquez-Rodas, Ivan; Robert, Caroline; Rutkowski, Piotr; Menzies, Alexander M; Eigentler, Thomas; Ascierto, Paolo A; Smylie, Michael; Schadendorf, Dirk; Ajaz, Mazhar; Svane, Inge Marie; Gonzalez, Rene; Rollin, Linda; Lord-Bessen, Jennifer; Saci, Abdel; Grigoryeva, Elena; Pigozzo, Jacopo